SARS-CoV-2 specific immunity in persons with a primary immune deficiency
Recruiting
- Conditions
- Primary Immune Deficiency
- Registration Number
- NL-OMON24202
- Lead Sponsor
- eiden University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
age 18 or older
- diagnosed with primary immune deficiency and a patient at the Leiden University Medical Center
- proof of having had COVID-19 by PCR, either by GGD (municipal Health Center) of LUMC
Exclusion Criteria
- vaccinated against SARS-CoV-2
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. SARS-CoV-2 specific T-cell immunity: CD4+ T cells and CD8+ T cells against SARS-CoV-2 structural proteins (N, M and S)<br>2. SARS-CoV-2 specific neutralizing antibodies
- Secondary Outcome Measures
Name Time Method